⌕
Staar Surgical · STAA · Nasdaq
Tenet 47 · Mixed
Compare
$26.19−0.77%Market openTenet 47 · Mixed
$26.19−0.20 (−0.77%)
Market open · 15-min delayed · as of 12:08 PM ET· Nasdaq · USD

Staar Surgical (STAA) Earnings Forecast

Analysts expect Staar Surgical (STAA) to earn $0.35 a share in FY26, the average of 5 estimates as of Nov 13, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice

2 figures withheld by our checks. Each blank figure names its reason.

FY26 consensus EPS
$0.35
5 analysts
FY27 consensus EPS
$0.58
5 analysts · low $0.54, high $0.66
EPS revisions, 30 days
+19.1%
$0.29 to $0.35
Disagreement, FY26
3.4%
high to low, $0.34 to $0.35

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 13, 2026 · we check it nightly

Analysts expect Staar Surgical to earn $1.08 a share in FY30, growing about 33% a year; 8 analysts publish an estimate for FY30.

Forward P/E · FY26E
76.3×
$26.39 (as of close, Nov 13, 2026) ÷ $0.35 consensus EPS
Coverage · FY26
5 · 7
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $0.35, down 51.6% in 91 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 91 days. One step per nightly change.

−71.1%−30.1%+10.8%FY27 −38.9%FY26 −51.6%Aug 15Nov 13
EPS30 days90 daysshown aboveSince Jul 6
FY265 analysts▲ +19.1%$0.29 to $0.35▼ −51.6%$0.71 to $0.35▼ −51.5%$0.71 to $0.35
FY275 analysts▲ +7.0%$0.55 to $0.58▼ −38.9%$0.96 to $0.58▼ −38.9%$0.96 to $0.58
Oct '265 analysts◆ 0.0%$0.05 to $0.05▼ −65.6%$0.15 to $0.05▼ −65.6%$0.15 to $0.05
Oct '265 analysts◆ 0.0%$0.05 to $0.05▼ −65.6%$0.15 to $0.05▼ −65.6%$0.15 to $0.05

Contributors at both ends of the window: FY26 6 and 5. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 13, 2026 · consensus as of Nov 13, 2026

Pick a fiscal year and a multiple and the sum runs on the numbers the Street published.

Consensus EPS · FY27
$0.58
5 analysts · low $0.54, high $0.66 · thin coverage
Multiple · yours
We hold no multiple of our own for this company, neither today's nor a fiscal-year record, so the multiple can only be yours.
Receipt · STAA · FY27Nov 13, 2026
Implied, a share
Waiting
Drag the multipleShaded: where Staar Surgical's P/E sat at each fiscal year end, FY10 to FY23. Each dot is one year.
5×10×20×30×40×50×60×

Each point on the line is a multiple, and the flag is the price it implies for FY27. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

You are paying 76.3 times the FY26 consensus for earnings the Street expects to grow about 44% a year to FY28. That is 1.7 times the growth rate.Show today's multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY10 to FY23 · over 5 fiscal years, with 4 years of near-zero earnings left out. The mark is the median of the last 5.
2,561.8× today
4.0× low164.1× high
72.3× median
Forward 76.3× is a different measure, so it is not placed on a trailing record. Today's mark is the trailing 2,561.8×, on the same basis as every year behind it.

How much do analysts disagree?

For FY30, estimates run from $1.00 to $1.13 around an average of $1.08, drawn by 8 analysts.

FY26E5 analysts
$0.34 to $0.35 · 3.4%
FY27E5 analysts
$0.54 to $0.66 · 19.8%
FY28E9 analysts
$0.63 to $0.83 · 27.0%
FY29E6 analysts
$0.83 to $0.94 · 12.7%
FY30E8 analysts
$1.00 to $1.13 · 12.7%

The dashed line is FY25 filed $−1.62, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.

Is next quarter a high bar or an easy one?

Analysts expect Staar Surgical to lose $0.05 a share in the January quarter, the average of 3 estimates. We hold no expected date for the next report. Last quarter, which ended in October, Staar Surgical earned $0.11 a share. Analysts had expected $0.05, so it came in 116.8% higher.

0
$−0.36
$−0.05high $−0.02
low $−0.06
Jan 2026 quarterfiled · GAAPJan 2027 quarterconsensus · Street basis · 3 analysts
Expected report
Not held
No expected date is published for this company's next report, so none is printed here.
Revenue expected · January quarter
$69.0M
6 analysts, 66.9 to 72.9 in $M · 57.8 in the same quarter a year ago

A year ago this quarter was a loss, so the change from it is not a percentage and none is printed. Last quarter's comparison is measured against the last estimate we hold for that quarter rather than the one from the night before the report, because we hold only the date its report was filed, which can trail the results release by days or weeks. For the January quarter, analysts expect a loss of $0.04 a share.

Does Staar Surgical usually beat or miss?

So far we have checked 4 quarters, of which 3 came in above the estimate we held. We add a quarter to this record each time Staar Surgical reports.

We started recording estimates on Jul 6, 2026, so quarters that reported before that date cannot be checked.

Before our record
Dec '23
Our record, one quarter per report
Mar '24left out · adjusted
Jun '24left out · adjusted
+11.2%
Sep '24reaction
−1.7%
Dec '24left out · basis
Mar '25left out · adjusted
Jun '25left out
Sep '25left out · adjusted
−300.0%
Jan '26reaction
+1.6%
+84.4%
Apr '26reaction
+8.9%
Jul '26left out · adjusted
+116.8%
Oct '26reaction
filing date only
Jan '27not reported yet
Checked so far
4 quarters
one more every report
Beat expectations
3 of 4
full details on the Earnings tab
Share price reaction
Not held
we hold only the filing date for that report, which can trail the release, so no move is shown
Typical gap vs estimate
+47.8%
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for Staar Surgical on Jul 6, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact. Sep '24, Jan '26, Apr '26, Oct '26 are drawn hollow: we hold no estimate for those quarters recorded strictly before the report, so it is scored against the last estimate we hold rather than the night-before one.

The Street expects sales to grow 8.9% in FY27 and EPS 69.1%. Little of it is sales: the net margin moves from 5.0% to 8.1%, and the implied share count from about 49.3M to 50.9M, so these numbers assume no buyback.Show the decomposition and the margin ladderHide the decomposition
FY27 EPS growth, in points
Revenue growth+8.9
Net margin change+65.9
Share count change−5.7
EPS growth+69.1
Legs are rounded to a tenth of a point and the largest remainder carries the difference, so they add to the total. Implied shares = consensus net income ÷ consensus EPS, a direction rather than a decimal.
5 analysts publish an EPS estimate for FY26 and 7 publish revenue. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
75
FY26E
85
FY27E
109
FY28E
56
FY29E
48
FY30E
The FY26 panel held 6 analysts when our record of it began on Jul 6, 2026 and holds 5 tonight.

The full consensus, year by year

Consensus as of Nov 13, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
0.20.40.5historyStreet forecastFY22FY25FY30E

Coverage thins with distance: 7 revenue estimates for FY26, 4 for FY30.

Diluted EPS · $filed · consensus average · band = low to high
−1.79−0.271.24historyStreet forecastFY22FY25FY30E

Out-year bands widen as fewer analysts publish: 5 EPS estimates for FY26, 8 for FY30.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed0.2—−1.62————as filed2,561.8×
FY26E0.30.3 to 0.3▲41.9%a0.350.34 to 0.35n/ca0.00.00.057 · 576.3×
FY27E0.40.4 to 0.4▲8.9%0.580.54 to 0.66▲69.1%0.00.00.058 · 545.1×
FY28E0.40.4 to 0.4▲8.6%0.720.63 to 0.83n/cb0.10.00.0510 · 936.8×
FY29E0.50.4 to 0.5n/cb0.890.83 to 0.94▲24.3%0.10.00.055 · 629.6×
FY30E0.50.5 to 0.5▲10.2%1.081.00 to 1.13▲20.6%0.10.10.054 · 824.5×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 5 EPS estimates for FY26, 7 for revenue. Not investment advice.

What do analysts expect Staar Surgical to earn in FY26?

Analysts expect Staar Surgical to earn $0.35 a share in FY26, the average of 5 estimates as of Nov 13, 2026.

What is Staar Surgical's earnings forecast for FY27?

The FY27 consensus for Staar Surgical is $0.58 a share from 5 analysts, with a low of $0.54 and a high of $0.66, as of Nov 13, 2026.

Have analysts raised Staar Surgical's earnings estimates?

Staar Surgical's FY26 EPS consensus fell 51.6% in 91 days, from $0.71 to $0.35, as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.